structure of 2,4-Dibromo-3,6-difluoroiodobenzene

2,4-Dibromo-3,6-difluoroiodobenzene

CAS No.: 1000577-89-8
M. Wt: 397.78100
M. Fa: C6HBr2F2I
InChI Key: NXWFCDNFLFJFCO-UHFFFAOYSA-N
Appearance: Solid

Names and Identifiers of 2,4-Dibromo-3,6-difluoroiodobenzene

CAS Number

1000577-89-8

MDL Number

MFCD09878119

IUPAC Name

1,3-dibromo-2,5-difluoro-4-iodobenzene

InChI

InChI=1S/C6HBr2F2I/c7-2-1-3(9)6(11)4(8)5(2)10/h1H

InChIKey

NXWFCDNFLFJFCO-UHFFFAOYSA-N

Canonical SMILES

FC1=CC(Br)=C(F)C(Br)=C1I

UNSPSC Code

12352100

Physical and chemical properties of 2,4-Dibromo-3,6-difluoroiodobenzene

Exact Mass

395.74600

LogP

4.09440

Molecular Formula

C6HBr2F2I

Molecular Weight

397.78100

Safety Information of 2,4-Dibromo-3,6-difluoroiodobenzene

Pictograms

Signal Word

 Warning

Safety Data Sheet
Supports customized editing of SDS information and downloading in PDF documents.

Applications of 2,4-Dibromo-3,6-difluoroiodobenzene

1,3-Dibromo-2,5-difluoro-4-iodobenzene has diverse applications across various fields:

  • Organic Synthesis: It serves as a building block for synthesizing complex organic molecules.
  • Pharmaceuticals: The compound is explored for its potential in drug development.
  • Materials Science: It is used in creating specialty chemicals and advanced materials, such as polymers and electronic components.

Interaction Studies of 2,4-Dibromo-3,6-difluoroiodobenzene

Studies on the interactions of 1,3-Dibromo-2,5-difluoro-4-iodobenzene focus on its reactivity profiles in various chemical environments. The compound's behavior in nucleophilic substitution reactions and coupling reactions has been particularly noted. Additionally, research into its biological interactions is ongoing to determine its efficacy as a pharmaceutical agent or probe.

Biological Activity of 2,4-Dibromo-3,6-difluoroiodobenzene

Research indicates that 1,3-Dibromo-2,5-difluoro-4-iodobenzene has potential biological activity. It may serve as a probe in biochemical assays and is being investigated for applications in pharmaceuticals. The compound's unique halogen composition could enhance its interaction with biological targets, although specific biological mechanisms and effects require further study.